Keevin Bernstein

1.1k total citations
23 papers, 844 citations indexed

About

Keevin Bernstein is a scholar working on Nephrology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Keevin Bernstein has authored 23 papers receiving a total of 844 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 5 papers in Hematology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Keevin Bernstein's work include Dialysis and Renal Disease Management (7 papers), Central Venous Catheters and Hemodialysis (4 papers) and Chronic Kidney Disease and Diabetes (2 papers). Keevin Bernstein is often cited by papers focused on Dialysis and Renal Disease Management (7 papers), Central Venous Catheters and Hemodialysis (4 papers) and Chronic Kidney Disease and Diabetes (2 papers). Keevin Bernstein collaborates with scholars based in Canada, United Kingdom and United States. Keevin Bernstein's co-authors include Daniel T. O’Connor, Celia M.T. Greenwood, William F. Clark, Peter A. F. Morrin, David Churchill, Susan Lavoie, Susan Ritchie, Daniel Cattran, Lavern M. Vercaigne and S. Brian Penner and has published in prestigious journals such as New England Journal of Medicine, Kidney International and American Journal of Kidney Diseases.

In The Last Decade

Keevin Bernstein

23 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keevin Bernstein Canada 14 327 206 186 100 99 23 844
John T. Crosson United States 22 362 1.1× 127 0.6× 222 1.2× 128 1.3× 154 1.6× 40 1.3k
Kenichi Maruyama Japan 19 117 0.4× 232 1.1× 159 0.9× 189 1.9× 212 2.1× 76 1.0k
Tomasz Hryszko Poland 16 214 0.7× 109 0.5× 88 0.5× 59 0.6× 140 1.4× 74 703
Germán Ramírez United States 22 308 0.9× 328 1.6× 219 1.2× 129 1.3× 176 1.8× 74 1.4k
Alper Soylu Türkiye 17 322 1.0× 442 2.1× 285 1.5× 145 1.4× 242 2.4× 137 1.2k
Erkin Serdaroğlu Türkiye 17 266 0.8× 179 0.9× 171 0.9× 57 0.6× 75 0.8× 54 767
Dietrich Michalk Germany 21 275 0.8× 257 1.2× 184 1.0× 99 1.0× 168 1.7× 65 1.1k
E. Bérard France 19 204 0.6× 127 0.6× 136 0.7× 74 0.7× 162 1.6× 76 873
Wai Cheung United States 14 385 1.2× 65 0.3× 129 0.7× 135 1.4× 64 0.6× 18 854
Jovan Milutinovic United States 16 313 1.0× 183 0.9× 278 1.5× 48 0.5× 112 1.1× 29 887

Countries citing papers authored by Keevin Bernstein

Since Specialization
Citations

This map shows the geographic impact of Keevin Bernstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keevin Bernstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keevin Bernstein more than expected).

Fields of papers citing papers by Keevin Bernstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keevin Bernstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keevin Bernstein. The network helps show where Keevin Bernstein may publish in the future.

Co-authorship network of co-authors of Keevin Bernstein

This figure shows the co-authorship network connecting the top 25 collaborators of Keevin Bernstein. A scholar is included among the top collaborators of Keevin Bernstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keevin Bernstein. Keevin Bernstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Collister, David, et al.. (2017). ANCA Associated Vasculitis Secondary to Levamisole-Adultered Cocaine with Associated Membranous Nephropathy: A Case Series. American Journal of Nephrology. 45(3). 209–216. 28 indexed citations
2.
Komenda, Paul, Nancy Yu, Stella Leung, et al.. (2015). Determination of the optimal case definition for the diagnosis of end-stage renal disease from administrative claims data in Manitoba, Canada. CMAJ Open. 3(3). E264–E269. 10 indexed citations
3.
Komenda, Paul, Nancy Yu, Stella Leung, et al.. (2015). Secular trends in end-stage renal disease requiring dialysis in Manitoba, Canada: a population-based study. CMAJ Open. 3(1). E8–E14. 16 indexed citations
4.
5.
Zacharias, James, et al.. (2011). Home Hemodialysis in the Remote Canadian North: Treatment in Manitoba Fly‐in Communities. Seminars in Dialysis. 24(6). 653–657. 14 indexed citations
6.
Bernstein, Keevin, et al.. (2010). Model for Equitable Care and Outcomes for Remote Full Care Hemodialysis Units. Clinical Journal of the American Society of Nephrology. 5(4). 645–651. 20 indexed citations
7.
Raymond, Colette B., et al.. (2005). Erythropoietin-Alpha Dosage Requirements in a Provincial Hemodialysis Population: Effect of Switching from Subcutaneous to Intravenous Administration. Nephron Clinical Practice. 102(3-4). c88–c92. 6 indexed citations
8.
Vercaigne, Lavern M., Sheryl Zelenitsky, I. Findlay, Keevin Bernstein, & S. Brian Penner. (2002). An in vitro evaluation of the antibiotic/heparin lock to sterilize central venous haemodialysis catheters. Journal of Antimicrobial Chemotherapy. 49(4). 693–696. 23 indexed citations
9.
Vercaigne, Lavern M., et al.. (2000). Antibiotic‐Heparin Lock: In Vitro Antibiotic Stability Combined with Heparin in a Central Venous Catheter. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(4). 394–399. 62 indexed citations
10.
Cattran, Daniel, Celia M.T. Greenwood, Susan Ritchie, et al.. (1995). A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Kidney International. 47(4). 1130–1135. 157 indexed citations
11.
McKenna, Rachel M., et al.. (1994). Increased Production of Tumor Necrosis Factor Activity by Hemodialysis but Not Peritoneal Dialysis Patients. ˜The œNephron journals/Nephron journals. 67(2). 190–196. 14 indexed citations
12.
McKenna, Rachel M., et al.. (1994). Inflammatory cytokine mRNA in patients with chronic renal failure. Cytokine. 6(5). 569–569. 1 indexed citations
13.
Vigushin, David M., J Gough, Donald R. Allan, et al.. (1994). Familial nephropathic systemic amyloidosis caused by apolipoprotein Al variant Arg26. QJM. 87(3). 149–54. 47 indexed citations
14.
Bernstein, Keevin, et al.. (1993). [Early infantile autism and excessive aerophagy with symptomatic megacolon and ileus in a case of Ehlers-Danlos syndrome].. PubMed. 31(4). 259–67. 24 indexed citations
15.
Rush, David N., et al.. (1993). Production of Tumor Necrosis Factor Alpha and Hemodialysis. ˜The œNephron journals/Nephron journals. 65(2). 273–277. 23 indexed citations
16.
Cole, Edward, Daniel C. Cattran, Alexander Magil, et al.. (1992). A Prospective Randomized Trial of Plasma Exchange as Additive Therapy in Idiopathic Crescentic Glomerulonephritis. American Journal of Kidney Diseases. 20(3). 261–269. 104 indexed citations
17.
Holton, Donna, et al.. (1991). Efficacy of mupirocin nasal ointment in eradicating Staphylococcus aureus nasal carriage in chronic haemodialysis patients. Journal of Hospital Infection. 17(2). 133–137. 60 indexed citations
18.
Penner, S. Brian, Keevin Bernstein, & A. Fine. (1990). Changes in endogenous creatinine clearance in man on a controlled protein diet: effect of route of administration of a protein load.. PubMed. 13(5). 233–6. 3 indexed citations
19.
O’Connor, Daniel T. & Keevin Bernstein. (1984). Radioimmunoassay of Chromogranin a in Plasma as a Measure of Exocytotic Sympathoadrenal Activity in Normal Subjects and Patients with Pheochromocytoma. New England Journal of Medicine. 311(12). 764–770. 193 indexed citations
20.
Bernstein, Keevin, et al.. (1983). Nadolol: Evidence for Sympathetic Nerve Inhibition by a Beta Blocker in Essential Hypertension. Journal of Hypertension. 1(3). 291–296. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John T. Crosson Breakdown of academic impact, for papers by Kenichi Maruyama Breakdown of academic impact, for papers by Tomasz Hryszko Breakdown of academic impact, for papers by Germán Ramírez Breakdown of academic impact, for papers by Alper Soylu Breakdown of academic impact, for papers by Erkin Serdaroğlu Breakdown of academic impact, for papers by Dietrich Michalk Breakdown of academic impact, for papers by E. Bérard Breakdown of academic impact, for papers by Wai Cheung Breakdown of academic impact, for papers by Jovan Milutinovic
Rankless by CCL
2026